Denosumab
-
Subject Areas on Research
- 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.
- Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.
- Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer.
- Denosumab for the treatment of osteoporosis.
- Development, reliability, and validity of a new Preference and Satisfaction Questionnaire.
- New and emerging therapies for bone metastases in genitourinary cancers.
- Non-exposed bisphosphonate-related osteonecrosis of the jaw: a critical assessment of current definition, staging, and treatment guidelines.
- Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study.
- Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study.
- Preference and satisfaction with a 6-month subcutaneous injection versus a weekly tablet for treatment of low bone mass.
- The role of Denosumab in joint preservation for patients with giant cell tumour of bone.
- Treatment of Chondroblastoma with Denosumab: A Case Report with a Correlative Analysis of Effect on the RANK Signaling Pathway.
- Using negative control outcomes to assess the comparability of treatment groups among women with osteoporosis in the United States.